Ionis Pharmaceuticals Cash Flow Statement (2009-2026) | IONS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-80.88M	-82.47M	224.61M	-65.17M	-105.14M	-46.99M	-52.43M	-124.34M	-85.25M	-147.41M	-9.26M	-142.80M	-66.27M	-140.48M	-105.01M	-146.94M	123.55M	-128.61M	151.79M	-92.53M
Depreciation and Depletion (Quarter)	4.03M	3.71M	3.82M	3.70M	3.78M	3.82M	3.03M	2.60M	2.62M	2.52M	2.54M	2.55M	2.47M	2.36M	2.24M	2.23M	2.27M	2.25M	3.26M	3.30M
Share-based Compensation (Quarter)	30.02M	30.54M	22.26M	26.24M	24.50M	23.84M	25.69M	26.95M	26.56M	25.96M	26.34M	31.34M	30.73M	31.98M	36.15M	29.72M	29.69M	31.15M	43.32M	43.27M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)			0.83M				0.96M				1.05M				1.19M				0.05M
Gains from Investment Securities (Quarter)	0.26M	0.28M	6.64M	0.30M	0.01M	0.33M	-0.88M	-0.53M	0.83M	-1.73M	1.43M	0.01M	-1.21M	1.20M		-1.85M	9.10M	2.18M	77.50M	-0.01M
Asset Writedowns and Impairment (Quarter)	0.61M	0.32M	1.56M	0.11M	0.84M	0.20M	0.88M	0.45M	0.33M	0.07M	0.97M	0.13M	0.26M	0.62M	2.02M	0.06M	0.24M	-3.94M	4.63M	0.04M
Non-cash Items (Quarter)	79.00M	65.30M	49.60M	67.70M	54.30M	50.90M	0.80M	60.20M	50.50M	44.10M	36.60M	71.10M	61.60M	54.10M	0.20M	51.90M	42.30M	37.20M	5.70M	69.50M
Cash from Operations (Quarter)	-62.65M	-55.57M	203.69M	-31.65M	-18.10M	-24.43M	-200.19M	-133.99M	-97.36M	-109.02M	32.87M	-149.94M	-119.88M	-114.99M	-116.14M	-150.78M	151.34M	-131.44M	-137.71M	-792.82M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	4.80M	0.96M	0.61M	0.59M	0.71M	0.67M	-9.36M	5.04M	-0.22M	-2.92M	0.66M	9.26M	-4.30M	23.33M	-18.24M	7.11M	-1.93M	1.63M	-4.36M	0.66M
Amortization of Deferred Charges (Quarter)	1.33M	1.39M	1.37M	1.34M	1.34M	1.35M	1.34M	1.49M	1.48M	1.70M	1.66M	1.67M	1.67M	1.68M	1.67M	1.64M	1.65M	1.65M	1.97M	2.35M
Depreciation & Amortization (CF) (Quarter)	4.03M	3.71M	3.82M	3.70M	3.78M	3.82M	3.03M	2.60M	2.62M	2.52M	2.54M	2.55M	2.47M	2.36M	2.24M	2.23M	2.27M	2.25M	3.26M	3.30M
Change in Working Capital
Change in Inventory (Quarter)	1.90M	-1.17M	1.88M	-0.77M	-4.22M	0.83M	-1.17M	0.17M	3.34M	0.10M	-1.13M	-0.50M	0.80M	-0.27M	5.04M	-1.01M	13.47M	2.13M	-0.93M	-0.34M
Change in Account Payables (Quarter)	6.75M	-7.92M	4.74M	2.88M	-5.55M	8.28M	-4.51M	-10.29M	15.81M	-17.98M	20.58M	0.06M	-17.12M	-2.15M	35.20M	0.09M	-20.40M	-8.81M	13.76M	-3.10M
Change in Accured Expenses (Quarter)	-23.60M	2.10M	6.49M	-22.29M	8.46M	52.09M	-27.89M	-28.46M	8.60M	-4.36M	42.77M	-46.19M	6.99M	12.03M	-15.82M	0.33M	-23.38M	110.73M	-41.06M	21.00M
Change in Taxes (Quarter)	0.55M	-0.42M	-0.41M	0.86M	-0.89M	0.00M	6.23M	11.04M	7.45M	6.34M	-28.92M	-13.87M	12.00M	-0.24M	-0.01M	-25.97M	26.02M	0.02M	2.61M	0.16M
Other Working Capital Changes (Quarter)	-26.76M	-21.13M	-11.22M	7.22M	-48.23M	41.99M	26.25M	-13.04M	32.73M	-1.37M	-4.36M	-11.05M	20.43M	-151.90M	-14.30M	12.37M	10.17M	100.95M	-193.22M	-20.82M
Investing Activities
Capital Expenditures (Quarter)	4.36M	3.32M	2.50M	2.71M	3.33M	5.54M	4.14M	10.47M	12.01M	2.14M	-0.82M	4.49M	6.23M	9.06M	25.50M	12.58M	12.30M	5.27M	-29.67M	21.76M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)	1.95M	1.28M	1.49M	0.83M	1.17M	1.52M	0.87M	1.25M	1.06M	1.10M	0.77M	1.24M	14.03M	-12.75M	2.55M	0.65M	1.96M	1.66M	1.36M	1.49M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)	315.95M	324.00M	292.33M	178.84M	201.54M	383.73M	225.05M	374.36M	326.67M	492.69M	390.95M	600.84M	367.58M	370.87M	429.89M	494.75M	385.79M	422.21M	395.12M	752.82M
Cash from Investing Activities (Quarter)	-101.03M	121.97M	95.11M	-287.55M	-3.30M	-183.93M	212.15M	-325.64M	69.52M	68.71M	-26.71M	76.11M	62.45M	-340.80M	68.21M	170.46M	-120.07M	91.34M	-419.50M	536.82M
Financing Activities
Other financing activities (Quarter)	0.46M	0.49M	0.44M	9.17M	0.40M	0.64M	0.74M			0.52M	-14.18M
Cash from Financing Activities (Quarter)	314.54M	1.46M	-62.49M	-7.33M	1.22M	1.83M	-51.02M	492.09M	143.54M	-32.27M	40.72M	23.57M	2.56M	496.05M	-44.12M	2.20M	1.25M	81.22M	591.18M	57.26M
Additional items
Exchange Rate Effect (Quarter)	0.10M	-0.02M	-0.07M	-0.15M	-0.41M	-0.40M	0.55M	0.10M	0.07M	-0.15M	0.33M	-0.11M	-0.02M	0.35M	-0.49M	0.23M	0.59M	-0.08M	-0.04M	-0.14M
Change in Cash (Quarter)	150.96M	67.83M	236.24M	-326.68M	-20.60M	-206.92M	-38.52M	32.56M	115.76M	-72.73M	47.21M	-50.38M	-54.90M	40.61M	-92.53M	22.11M	33.11M	41.04M	33.92M	-198.88M
Free Cash Flow (Quarter)	-67.01M	-58.90M	201.19M	-34.35M	-21.43M	-29.97M	-204.33M	-144.46M	-109.38M	-111.16M	33.68M	-154.43M	-126.11M	-124.05M	-141.64M	-163.35M	139.03M	-136.71M	-108.03M	-814.58M
Net Cash Flow (Quarter)	150.86M	67.86M	236.31M	-326.52M	-20.18M	-206.53M	-39.07M	32.45M	115.69M	-72.58M	46.88M	-50.26M	-54.87M	40.26M	-92.04M	21.88M	32.52M	41.12M	33.96M	-198.74M

Research Tools

Ionis Pharmaceuticals Cash Flow Statement (2009-2026) | IONS

Create an account

Sign In

Reset Password